Platinum Industries Ltd

- No explicit mention of any current or planned fundraising through debt or equity was made during the call. - The company emphasized a strong liquidity position to fund ongoing operations and future investments. - Net debt remained minimal, reflecting prudent financial management. - The management highlighted plans to invest in capacity expansion and new facilities, including the Egypt plant and oleo chemical plant, supported by internal accruals. - They reiterated maintaining financial discipline while investing in capacity, technology, and R&D. - No concrete CapEx plans were shared for new plants in Europe or the US. - Overall, the focus is on organic growth funded through internal resources without mentioning fresh equity or debt raises.

- Platinum Industries is investing in expanding production capabilities at the Indian facility, including the Palghar plant, and setting up the new manufacturing facility in Egypt, expected to start commercial operations in Q3 FY27. - They are building capacities for oleo-based derivatives with design and setup already started; the oleo chemicals plant readiness is expected within the next 1.5 years. - No immediate CapEx plans for manufacturing footprint expansion in Europe or the US, but the company is studying these markets and remains open to opportunities when viable. - CapEx during FY26 focused on capacity expansion at Indian and Egypt plants, aligning with long-term growth and diversification strategies. - Emphasis on capacity augmentation, technology upgrades, and R&D investments to support sustainable growth and product innovation.

- Platinum Industries targets over 40% revenue growth in FY27. - They expect about 10% of FY27 revenue from the Egypt facility; the rest from India. - Aiming for a 35% CAGR from FY26 to FY29 driven by facility ramp-ups, product innovation, and geographic diversification. - Growth to be led by increased contributions from CPVC and lead-free products. - CPVC sales accounted for ~30% of revenue in FY26 and expected to grow significantly. - Egypt plant expected to start commercial operations in Q3 FY27 with a potential peak revenue of over INR 600 crore. - Oleo chemicals segment has started sales in FY26 and expected to contribute meaningfully with a target of INR 55-60 crore revenue in FY27. - Capacity expansions in India (Palghar facility) planned with optimized utilization to support growth. - Focus on new product introductions across polymer families to support future growth.

- Platinum Industries targets a **40% revenue growth in FY27**, driven mainly by the Indian facility (90%) and 10% from the Egypt facility starting Q3 FY27. - They aim for a **35% CAGR in revenue from FY26 to FY29**, supported by scaling up the Egypt plant and expanded Indian operations. - EBITDA margins are expected to stabilize between **13%-15% in FY27**. - Growth drivers include increasing sales of **CPVC and lead-free products**, which contributed 30% of FY26 revenue, and further expansion in **oleo chemicals**. - Egypt plant’s peak revenue potential is projected to exceed **INR 600 crore**, with breakeven at around 30-35% utilization. - Operating efficiencies, new product introductions, and innovation in sustainability are expected to enhance profitability. - Strong financial discipline and cost optimization efforts are anticipated to sustain **PAT growth in line with revenue expansion**.

The transcript from Platinum Industries Limited's Q4 & FY26 conference call does not explicitly mention the current or expected order book or pending orders. However, relevant insights include: - The company is witnessing strong demand momentum in the PVC and CPVC pipe and fitting markets. - Revenue growth guidance for FY27 is 40%, driven by Indian and Egypt facilities. - Egypt facility revenue contribution expected at 10% in FY27, beginning production in Q3 FY27. - CPVC business is growing, contributing around 30% of revenue in FY26. - New product development and entry into oleo chemicals segment indicate incoming demand pipeline. - The management expressed confidence in continued volume growth supported by CPVC, oleo chemicals, and lead-free products. There is no specific quantitative data provided on the order book or pending orders in the call transcript.